Cancer News and Research

Latest Cancer News and Research

Ovarian lesions seen on an ultrasound effectively predict cancer risk

The appearance of ovarian lesions on ultrasound is an effective predictor of cancer risk that can help women avoid unnecessary surgery, according to a new study published in the journal Radiology.

22 Mar 2022

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Researchers have determined the effect of booster immunization on the levels of antibodies generated, against SARS-CoV-2 variants, including the Omicron strain, in cancer patients with or without active B cell-targeted therapy.

22 Mar 2022

Research reveals significant decrease in gastrointestinal infections during first 6 months of the pandemic

The number of reported gastrointestinal infection outbreaks more than halved during the first 6 months of the COVID-19 pandemic in the UK, compared with the previous 5-year average, while lab confirmed cases fell by a third, finds research published in the open access journal BMJ Open.

22 Mar 2022

Researchers identify a protein that protects against breast cancer growth

Researchers at Karolinska Institutet in Sweden have identified a protein that protects against breast tumor growth and that can be linked to a better prognosis in breast cancer patients.

22 Mar 2022

The obstacles to developing high-throughput 3D wound healing models

In this interview, News-Medical talks to Dr. Glauco Souza and Linda Boekestijn about their work in the wound healing space and how they devised a new high throughput 3D model for would healing.

From PromoCell 22 Mar 2022

Key mechanism that increases drug tolerance among microbial communities revealed

Research from the Francis Crick Institute has revealed a key mechanism which increases tolerance to drugs amongst microbial communities.

22 Mar 2022

Closed Loop Medicine announces completion of precision medicine clinical trial for patients with high blood pressure

Closed Loop Medicine Ltd announced today that the last patient has completed participation in a clinical trial investigating the Company’s integrated precision care product solution for patients with hypertension.

22 Mar 2022

Scientists reveal how 911 DNA checkpoint clamp helps repair the damaged DNA

When something goes wrong during DNA replication, cells call their own version of 911 to pause the process and fix the problem - a failsafe that is critical to maintaining health and staving off disease.

22 Mar 2022

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

The findings of a new study suggest that a ketogenic diet - which is low in carbohydrates and protein, but high in fat - helps to kill pancreatic cancer cells when combined with a triple-drug therapy developed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

22 Mar 2022

Study reveals novel tumor biomarker of aggressive cancers with poor prognosis

A study published in The Journal of Pathology reveals that many cancers that carry a poor prognosis express an altered form of human telomerase reverse transcriptase (hTERT), an enzyme that regulates the expression of multiple genes.

22 Mar 2022

Association between seropositivity and comorbidities after COVID-19 vaccination

In a recent study posted to the medRxiv* preprint server, researchers demonstrated that comorbidities attenuated the chance of seropositivity following coronavirus disease 2019 (COVID-19) vaccination.

22 Mar 2022

Researchers receive a combined $1 million grant to study RET-positive lung cancer

University of Colorado Cancer Center member Tejas Patil, MD, is one of three researchers to receive a combined $1 million grant from the Hamoui Foundation and LUNGevity Foundation to study RET-positive lung cancer.

21 Mar 2022

Novel screening platform flags 95% of stage 1 cancers

A novel screening platform has flagged more than 95 percent of stage 1 cancers, according to a pilot study published in Nature Communications Medicine. If validated by future studies, the approach offers a new way to detect the third-leading cause of U.S. cancer deaths in 2020.

21 Mar 2022

Researchers win NIH grant to treat human brain cancer with a drug previously used on canines

The National Institutes of Health is awarding a $3.8 million grant to John Rossmeisl, the Dr. and Mrs. Dorsey Taylor Mahin Professor of Neurology and Neurosurgery at the Virginia-Maryland College of Veterinary Medicine, and Waldemar Debinski, cancer biology professor at the Wake Forest School of Medicine.

21 Mar 2022

Using CRISPR/Cas to develop biosafety materials

Researchers discuss the use of the highly efficient CRISPR/Cas technologies to identify viral genome sequences for biosafety purposes.

21 Mar 2022

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

Researchers discuss the difference between transmitters and non-transmitters of SARS-CoV-2 in terms of their mean viral load.

21 Mar 2022

Research reveals enzyme-driven process that activates anti-cancer molecule

Years of toil in the laboratory have revealed how a marine bacterium makes a potent anti-cancer molecule.

21 Mar 2022

Researchers offer a clear picture of how the 9-1-1 clamp is recruited to sites of DNA damage

DNA is often likened to a blueprint. The particular sequence of As, Cs, Gs, and Ts in DNA provides information for building an organism.

21 Mar 2022

New computational approach creates spatial maps of single-cell data within tissues

A new computational approach developed by researchers at The University of Texas MD Anderson Cancer Center successfully combines data from parallel gene-expression profiling methods to create spatial maps of a given tissue at single-cell resolution.

21 Mar 2022

Trial reveals effectiveness of axi-cel as first-line treatment for high-risk lymphoma

Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer Center showed that first-line treatment with axicabtagene ciloleucel (axi-cel), a chimeric antigen receptor (CAR) T cell therapy, achieved a high rate of complete response in patients with high-risk large B-cell lymphoma (LBCL).

21 Mar 2022

Cancer News and Research

Latest Cancer News and Research

Ovarian lesions seen on an ultrasound effectively predict cancer risk

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Research reveals significant decrease in gastrointestinal infections during first 6 months of the pandemic

Researchers identify a protein that protects against breast cancer growth

The obstacles to developing high-throughput 3D wound healing models

Key mechanism that increases drug tolerance among microbial communities revealed

Closed Loop Medicine announces completion of precision medicine clinical trial for patients with high blood pressure

Scientists reveal how 911 DNA checkpoint clamp helps repair the damaged DNA

Study: Ketogenic diet helps kill pancreatic cancer cells when combined with a triple-drug therapy

Study reveals novel tumor biomarker of aggressive cancers with poor prognosis

Association between seropositivity and comorbidities after COVID-19 vaccination

Researchers receive a combined $1 million grant to study RET-positive lung cancer

Novel screening platform flags 95% of stage 1 cancers

Researchers win NIH grant to treat human brain cancer with a drug previously used on canines

Using CRISPR/Cas to develop biosafety materials

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

Research reveals enzyme-driven process that activates anti-cancer molecule

Researchers offer a clear picture of how the 9-1-1 clamp is recruited to sites of DNA damage

New computational approach creates spatial maps of single-cell data within tissues

Trial reveals effectiveness of axi-cel as first-line treatment for high-risk lymphoma

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in